BiCNU
Showing 1 - 25 of 49
HIV, Lymphoma Trial in Zhanjiang (KL-7SHRNA injection solution)
Recruiting
- HIV Infections
- Lymphoma
- KL-7SHRNA injection solution
-
Zhanjiang, Guangdong, ChinaAffiliated hospital of Guangdong medical university
Jun 24, 2023
Diffuse Large B Cell Lymphoma Trial in Saint Louis (Blinatumomab, Autologous stem cell transplant, Carmustine)
Active, not recruiting
- Diffuse Large B Cell Lymphoma
- Blinatumomab
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
May 4, 2022
Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)
Active, not recruiting
- Glioblastoma Multiforme
- VBI-1901
- +2 more
-
Los Angeles, California
- +3 more
Jun 27, 2022
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- +2 more
- Carmustine
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022
Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)
Completed
- Leukemia
- +3 more
- Sirolimus
- +6 more
-
Stanford, CaliforniaStanford University School of Medicine
Sep 16, 2021
Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)
Active, not recruiting
- Recurrent Adult Hodgkin Lymphoma
- basiliximab
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)
Completed
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- Bendamustine
- +8 more
-
New York, New YorkWeill Cornell Medical College
Feb 1, 2021
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)
Completed
- Diffuse Large Cell Lymphoma
- Lymphoma
- Zevalin
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 12, 2021
Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)
Recruiting
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
- Basiliximab
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 16, 2022
Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6
Withdrawn
- Recurrent Diffuse Large B-Cell Lymphoma
- +9 more
- Autologous Hematopoietic Stem Cell Transplantation
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2023
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
Mantle Cell Lymphoma Trial in France (Obinutuzumab, Dexamethasone, Aracytine)
Active, not recruiting
- Mantle Cell Lymphoma
- Obinutuzumab
- +6 more
-
Amiens, France
- +29 more
Sep 14, 2021
Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)
Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,
Recruiting
- Autoimmune Disease
- +18 more
- Anti-Thymocyte Globulin
- +9 more
-
Denver, Colorado
- +2 more
Feb 1, 2023
Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)
Completed
- Lymphoma
- B-cell Lymphoma
- Leukapheresis
- +7 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 27, 2020
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)
Completed
- Mantle Cell Lymphoma
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Jan 18, 2022
Lymphoma Trial in Duarte (biological, drug, procedure)
Completed
- Lymphoma
- lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 13, 2019
Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma Trial in Durham, Portland (procedure, drug, other)
Completed
- Plasma Cell Leukemia
- Recurrent Plasma Cell Myeloma
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Durham, North Carolina
- +1 more
Nov 19, 2020
Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)
Terminated
- Burkitt Lymphoma
- +6 more
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 30, 2020
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,
Completed
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 29, 2020
Adult DLBCL, B-Cell Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Seattle (Autologous Hematopoietic Stem Cell
Completed
- Adult Diffuse Large B-Cell Lymphoma
- +5 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 3, 2020
CD19 Positive, Mantle Cell Lymphoma, Recurrent DLBCL Trial in Houston (procedure, drug, biological)
Withdrawn
- CD19 Positive
- +6 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2020